MarkNtel Advisors recently published a detailed industry analysis of the Global Human Milk Oligosaccharides (HMO) Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Global Human Milk Oligosaccharides (HMO) Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2028
The Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28.
What are the major Driver the Global Human Milk Oligosaccharides (HMO) industry?
Increasing awareness of the Health Benefits of HMOs and the Rising Demand for Improved Infant Nutrition – There is a growing awareness of the crucial role of nutrition in early childhood development & long-term health outcomes. Since HMOs are naturally occurring components of breast milk, they have been linked to various health benefits, like a healthy gut microbiome, enhanced immunity, and protection against pathogens. This increased focus on infant health & nutrition is fueling the demand for HMOs in infant formula & baby food products worldwide. Numerous studies have cited the potential health benefits of HMOs for infants and created much evidence that supports the positive impact of HMOs on gut health, immune development, and overall well-being, which, in turn, has increased awareness & acceptance of HMOs among healthcare professionals, parents, & consumers. Hence, these factors are expected to drive the Global Human Milk Oligosaccharides (HMO) Market during 2023-28.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Access the detailed PDF Sample report –https://www.marknteladvisors.com/query/request-sample/hmo-market.html
What segments define the Global Human Milk Oligosaccharides (HMO) Market from 2023 to 2028? How do these segments contribute to market dynamics and growth?
- By Type
- 2’FL- Market Size & Forecast 2018-2028, (USD Million)
- 3’FL- Market Size & Forecast 2018-2028, (USD Million)
- 3’SL- Market Size & Forecast 2018-2028, (USD Million)
- 6’SL- Market Size & Forecast 2018-2028, (USD Million)
According to report, Of them all, 2′-FL dominates the Global Human Milk Oligosaccharides (HMO) Market, mainly on account of its structural similarity to & abundance in human breast milk, owing to which it is extensively studied & successfully produced on a commercial scale globally.
- By Application
- Infant formula- Market Size & Forecast 2018-2028, (USD Million)
- Functional food & beverage- Market Size & Forecast 2018-2028, (USD Million)
- Food supplements- Market Size & Forecast 2018-2028, (USD Million)
- Others-Market Size & Forecast 2018-2028, (USD Million)
According to report, Here, infant formula is the leading application for HMOs and is used extensively as a substitute for breast milk across various regions where breastfeeding rates are less.
- By Concentration
- Neutral- Market Size & Forecast 2018-2028, (USD Million)
- Acidic- Market Size & Forecast 2018-2028, (USD Million)
- Others– Market Size & Forecast 2018-2028, (USD Million)
- By Distribution Channel
- Hypermarkets & Supermarkets- Market Size & Forecast 2018-2028, (USD Million)
- Drug store or pharmacy- Market Size & Forecast 2018-2028, (USD Million)
- Mass merchandiser- Market Size & Forecast 2018-2028, (USD Million)
- Departmental Stores- Market Size & Forecast 2018-2028, (USD Million)
- Mono-brand Store-Market Size & Forecast 2018-2028, (USD Million)
- Specialty stores-Market Size & Forecast 2018-2028, (USD Million)
Geographical Analysis: Global Human Milk Oligosaccharides (HMO) Market
- By Region
- North America
- South America
- Europe
- Asia-Pacific
- Rest of World
Explore the Complete Global Human Milk Oligosaccharides (HMO) Market Analysis Report– https://www.marknteladvisors.com/research-library/hmo-market.html
Global Human Milk Oligosaccharides (HMO) Market Share & Competitive Landscape:
The Human Milk Oligosaccharides (HMO) Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.
Leading Companies in the Global Human Milk Oligosaccharides (HMO) Market are:
- Biosynth Carbosynth
- Hansen Holding A/S
- Dextra Laboratories Ltd
- DuPont Nutrition & Biosciences
- Elicityl S.A.
- Glycosyn
- Inbiose NV
- Medolac Laboratories
- Nestle Health Science
- ROYAL DSM
- BASF SE
- Abbott Laboratories
- GNUBIOTICS Sciences S.A.
- Dextra Laboratories
Global Human Milk Oligosaccharides (HMO) Industry Recent Developments
- On 18 November 2022, KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, Limited, completed the HMO production facility at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
- On 31 October 2022, FrieslandCampina got approval from Australia’s & New Zealand’s authorities for using its 2’-FL trademarked Aequival in infant milk formula, i.e., in line with expanding its HMO portfolio.
Questions Addressed in this Study
1.What factors are driving the Global Human Milk Oligosaccharides (HMO) Market growth?
2.How is the Global Human Milk Oligosaccharides (HMO) Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Global Human Milk Oligosaccharides (HMO) Market ?
4.What is the current size of the Global Human Milk Oligosaccharides (HMO) Market, and how is it projected to change in the future?
6.What is the future outlook for the Global Human Milk Oligosaccharides (HMO) Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/hmo-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
